Bio-Rad Laboratories Inc. Class A (NYSE: BIO) stock closed at 603.99 per share at the end of the most recent trading day (a 0.05% change compared to the prior day closing price) with a volume of 90.04K shares and market capitalization of 18.40B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 8000 people. Bio-Rad Laboratories Inc. Class A CEO is Norman Schwartz.

The one-year performance of Bio-Rad Laboratories Inc. Class A stock is 51.62%, while year-to-date (YTD) performance is 3.42%. BIO stock has a five-year performance of 332.02%. Its 52-week range is between 396.16 and 689, which gives BIO stock a 52-week price range ratio of 75.22%

Bio-Rad Laboratories Inc. Class A currently has a PE ratio of 4.70, a price-to-book (PB) ratio of 1.79, a price-to-sale (PS) ratio of 7.58, a price to cashflow ratio of 31.00, a PEG ratio of 2.32, a ROA of 35.09%, a ROC of 46.36% and a ROE of 47.15%. The company’s profit margin is 84.36%, its EBITDA margin is 199.10%, and its revenue ttm is $1.97 Billion , which makes it $79.68 revenue per share.

Of the last four earnings reports from Bio-Rad Laboratories Inc. Class A, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.50 for the next earnings report. Bio-Rad Laboratories Inc. Class A’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for Bio-Rad Laboratories Inc. Class A is Strong Buy (1), with a target price of $678.33, which is +10.27% compared to the current price. The earnings rating for Bio-Rad Laboratories Inc. Class A stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bio-Rad Laboratories Inc. Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bio-Rad Laboratories Inc. Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 9.08, ATR14 : 21.74, CCI20 : 191.14, Chaikin Money Flow : 0.04, MACD : -9.33, Money Flow Index : 54.46, ROC : 7.97, RSI : 39.39, STOCH (14,3) : 96.14, STOCH RSI : 0.45, UO : 59.32, Williams %R : -3.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bio-Rad Laboratories Inc. Class A in the last 12-months were: Andrew J. Last (Option Excercise at a value of $0), Annette Tumolo (Option Excercise at a value of $191 184), Annette Tumolo (Sold 1 200 shares of value $768 865 ), Dara Wright (Option Excercise at a value of $0), Giovanni Magni (Option Excercise at a value of $2 579 316), Giovanni Magni (Sold 15 229 shares of value $7 914 650 ), Michael Crowley (Option Excercise at a value of $0), Michael Crowley (Sold 1 874 shares of value $945 271 ), Norman Schwartz (Option Excercise at a value of $6 258 180), Ronald W. Hutton (Option Excercise at a value of $0), Ronald W. Hutton (Sold 443 shares of value $202 606 ), Timothy S. Ernst (Option Excercise at a value of $63 728), Timothy S. Ernst (Sold 923 shares of value $591 501 )